Search
for
Sort by
Research 601–630 of 1000+
- Adverse Hair Reactions to New Targeted Therapies for Cancer
- Follicular Unit Extraction for Hair Transplantation: An Update
- Compounding as a Current Therapeutic Option in Dermatology
- Scarring Alopecia
- JAK kinase pathway inhibitor drugs in patients with moderate-to-severe alopecia: a real-world experience
- Evolución de la técnica follicular unit extraction (FUE)
- Manifestaciones dermatológicas por Covid-19 y su aporte en la comprensión de la enfermedad
- Moniletrix. Observación de esta infrecuente displasia pilosa en dos hermanos. Reporte clínico y dermatoscópico
- Uso actual de la vitamina D en dermatología
- Polycystic ovarian syndrome in patients with schizophrenia treated with atypical anti-psychotics: A case control study
- Alopecia cicatrizal como manifestación de lupus eritematoso cutáneo
- Letter: Re: Hair Transplantation for Reconstruction of Scalp Defects Using Artificial Dermis
- Efecto en el sangrado perioperatorio durante la resección transuretral de la próstata tras un mes de tratamiento con dutasteride
- Tricotiodistrofia. Reporte de un caso
- Characterizing hair loss in female patients with systemic lupus erythematosus (SLE)
- Scalp-Reduction Revisited: A 10-Year Experience
- Ethical Principles for Everyone
- Blinding in Placebo-Controlled Trials
- Hair Tonic (Serum)
- Nociceptive and Nonnociceptive Roles of TRPV3 and Its “Druggability”
- Molecular Dissection of Mesenchymal–Epithelial Interactions in the Hair Follicle
- Genetic, hormonal and metabolic aspects of PCOS: an update
- A family business: stem cell progeny join the niche to regulate homeostasis
- Human hair follicle organ culture: theory, application and perspectives
- Structure of human type II 5 alpha-reductase gene.
- Thymosin β<sub>4</sub>increases hair growth by activation of hair follicle stem cells
- Obesity and polycystic ovary syndrome
- Diet and hair loss: effects of nutrient deficiency and supplement use
- Template for Skin Regeneration
- Cepharanthine: a review of the antiviral potential of a Japanese-approved alopecia drug in COVID-19